| Hans-Günter Meyer-Thompson | Buprenorphin
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder.
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder.
Frost, M., Bailey, G. L., Lintzeris, N., Strang, J., Dunlop, A., Nunes, E. V., Jansen, J. B., Frey, L. C., Weber, B., Haber, P., Oosman, S., Kim, S., and Tiberg, F. ( 2019)
Addiction, doi.org/10.1111/add.14636.